The Tpl2 Mutation Sluggish Impairs Type I IFN Production and Increases Susceptibility to Group B Streptococcal Disease1
暂无分享,去创建一个
B. Beutler | P. Krebs | A. Blasius | Celine Eidenschenk | Nengming Xiao | K. Brandl | Nora G. Smart | Yu Xia | Kevin Khovananth
[1] Frank Kaiser,et al. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells , 2009, The Journal of experimental medicine.
[2] S. Akira,et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells , 2009, Nature Immunology.
[3] A. Sher,et al. Tpl2 kinase regulates T cell interferon-γ production and host resistance to Toxoplasma gondii , 2008, The Journal of experimental medicine.
[4] Young-In Kim,et al. Role of bacterial DNA in macrophage activation by group B streptococci. , 2008, Microbes and infection.
[5] T. Kaisho. Type I interferon production by nucleic acid-stimulated dendritic cells. , 2008, Frontiers in bioscience : a journal and virtual library.
[6] Philip R. Cohen,et al. TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages , 2008, Journal of Cell Science.
[7] K. Schroder,et al. Differential Effects of CpG DNA on IFN-β Induction and STAT1 Activation in Murine Macrophages versus Dendritic Cells: Alternatively Activated STAT1 Negatively Regulates TLR Signaling in Macrophages1 , 2007, The Journal of Immunology.
[8] Steve Gerondakis,et al. Coordinating TLR‐activated signaling pathways in cells of the immune system , 2007, Immunology and cell biology.
[9] T. Leanderson,et al. Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria1 , 2007, The Journal of Immunology.
[10] F. Schmitz,et al. Interferon‐regulatory‐factor 1 controls Toll‐like receptor 9‐mediated IFN‐β production in myeloid dendritic cells , 2007 .
[11] Susan S. Taylor,et al. Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.
[12] I. Wilson,et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Dahiyat,et al. PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-α (Tnf), Does Not Impair Lymphoid Development1 , 2006, The Journal of Immunology.
[14] Zhengfan Jiang,et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. , 2006, Annual review of immunology.
[15] Steve Gerondakis,et al. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] B. Beutler,et al. Analysis of the MCMV resistome by ENU mutagenesis , 2006, Mammalian Genome.
[17] T. Decker,et al. The Yin and Yang of type I interferon activity in bacterial infection , 2005, Nature Reviews Immunology.
[18] Jeonghee Cho,et al. Tpl2 (Tumor Progression Locus 2) Phosphorylation at Thr290 Is Induced by Lipopolysaccharide via an Iκ-B Kinase-β-dependent Pathway and Is Required for Tpl2 Activation by External Signals* , 2005, Journal of Biological Chemistry.
[19] Zhengfan Jiang,et al. CD14 is required for MyD88-independent LPS signaling , 2005, Nature Immunology.
[20] Jeonghee Cho,et al. Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Cuozzo,et al. Phosphorylation of Threonine 290 in the Activation Loop of Tpl2/Cot Is Necessary but Not Sufficient for Kinase Activity* , 2004, Journal of Biological Chemistry.
[22] A. Masuda,et al. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. , 2004, The Journal of clinical investigation.
[23] D. Portnoy,et al. Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes , 2004, The Journal of experimental medicine.
[24] E. Unanue,et al. Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection , 2004, The Journal of experimental medicine.
[25] Ryan M. O’Connell,et al. Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection , 2004, The Journal of experimental medicine.
[26] S. Akira,et al. Dual Role of TLR2 and Myeloid Differentiation Factor 88 in a Mouse Model of Invasive Group B Streptococcal Disease 1 , 2004, The Journal of Immunology.
[27] R. Flavell,et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Trinchieri,et al. Mouse Strain Differences in Plasmacytoid Dendritic Cell Frequency and Function Revealed by a Novel Monoclonal Antibody , 2003, Journal of Immunology.
[29] Jiahuai Han,et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.
[30] Guo-Ping Zhou,et al. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.
[31] Shao-Cong Sun,et al. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. , 2003, Molecular cell.
[32] G. Piraino,et al. Mitogen-Activated Protein Kinases and NF-κB Are Involved in TNF-α Responses to Group B Streptococci1 , 2002, The Journal of Immunology.
[33] G. Piraino,et al. Mitogen-Activated Protein Kinases and NF- B Are Involved in TNF- Responses to Group B Streptococci , 2002 .
[34] S. Akira,et al. Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.
[35] G. Kollias,et al. TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway , 2000, Cell.
[36] J. Gutkind,et al. Multiple Mitogen-Activated Protein Kinase Signaling Pathways Connect the Cot Oncoprotein to the c-junPromoter and to Cellular Transformation , 2000, Molecular and Cellular Biology.
[37] P. Tsichlis,et al. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-κB , 1998, Oncogene.
[38] G. Kollias,et al. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.
[39] D. Pappin,et al. Activation of MEK‐1 and SEK‐1 by Tpl‐2 proto‐oncoprotein, a novel MAP kinase kinase kinase. , 1996, The EMBO journal.
[40] K. Goodrum,et al. Tumor necrosis factor alpha acts as an autocrine second signal with gamma interferon to induce nitric oxide in group B streptococcus-treated macrophages , 1995, Infection and immunity.
[41] B. Beutler,et al. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Mak,et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.
[43] G. Mancuso,et al. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection , 1993, Infection and immunity.